9th September 2020
USADA announced today that Tiffany Parlor, 31, of Wellington, Fla., an athlete in the sport of weightlifting, has received a four-year suspension for an anti-doping rule violation involving her possession and use and/or attempted use of a prohibited substance.
In addition to education and testing, robust anti-doping programs enable investigations stemming from various sources, including tips (including those received from the USADA Play Clean Tip Line) and whistleblowers. USADA investigations can reveal evidence about the actions of coaches, athletes, and support personnel who have engaged in, instigated, facilitated, or encouraged doping.
A USADA investigation into the shipment of prohibited substances from Transformix Peptides, an online seller of anabolic agents, led USADA to discover that Parlor made an online purchase of a product containing clenbuterol on January 4, 2018 that was shipped to her home. Clenbuterol is a Non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Parlor’s four-year period of ineligibility began on August 31, 2020, the date her sanction was imposed. In addition, Parlor has been disqualified from competitive results obtained on and subsequent to January 4, 2018, the date on which she purchased a prohibited substance, including forfeiture of any medals, points and prizes.